Methodology

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

Papi A, Jones PW, Dalvi PS, McAulay K, McIver T, Dissanayake S

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2431-2438

Published Date: 9 November 2015